Berkshire Hathaway Inc. vs AbbVie Inc.
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
Berkshire Hathaway Inc. (BRK-B) carries a "Neutral" signal with +0.7% revenue growth, while AbbVie Inc. (ABBV) is "Tailwind" with +10.0% revenue growth. Both companies report in the Financials and Healthcare sectors.
| Metric | Berkshire Hathaway Inc. (BRK-B) | AbbVie Inc. (ABBV) |
|---|---|---|
| Operator Signal | Neutral | Tailwind |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $93.7B | $16.6B |
| Revenue Growth | 0.7% | 10.0%* |
| Latest EPS | N/A | $1.02 |
| EPS Growth | N/A | N/A |
| Sector | Financials | Healthcare |
| Quarters Tracked | 8 | 8 |
Berkshire Hathaway Inc. (BRK-B) carries a "Neutral" signal with +0.7% revenue growth, while AbbVie Inc. (ABBV) is "Tailwind" with +10.0% revenue growth. Both companies report in the Financials and Healthcare sectors.